About the Authors
- A. T. Cohen
-
Affiliation Guy’s and St Thomas’ Hospitals, King’s College, London, United Kingdom
- M. Hamilton
-
Affiliation BMS, Princeton, United States of America
- S. A. Mitchell
-
* E-mail: smitchell@dresourcesgroup.com
Affiliation Abacus International, Bicester, United Kingdom
- H. Phatak
-
Affiliation BMS, Princeton, United States of America
- X. Liu
-
Affiliation Pfizer, New York, United States of America
- A. Bird
-
Affiliation Pfizer, Walton Oaks, United Kingdom
- D. Tushabe
-
Affiliation TUSH-D UK LTD, Birmingham, United Kingdom
- S. Batson
-
Affiliation Abacus International, Bicester, United Kingdom
Competing Interests
The authors have the following interests. This study was funded by Bristol Myers Squibb and Pfizer. Hamilton M. and Phatak H. are employed by Bristol Myers Squibb., Liu X. and Bird A. by Pfizer Ltd, Batson S. by Abacus International and Tushabe D. by TUSH-D UK LTD. At the time of this study, Claflin A. was a paid contractor of Pfizer Ltd. Cohen A. is a paid clinical consultant to Bristol Myers Squibb and Pfizer. Fowler H., Mitchell S.A., and Batson S. are paid consultants to Bristol Myers Squibb and Pfizer Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Analyzed the data: SB SAM MH. Wrote the paper: AC MH HP AB DT XL SAM SB. Defined the scope of the project: MH HP AB DT XL ATC SAM SB. Conducted the systematic review: SAM.